Trius Therapeutics Stock Price and Value Analysis

Should you buy Trius Therapeutics stock? (NASDAQ:TSRX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the TSRX Numbers

TSRX Price
(Trius Therapeutics stock price per share)
$13.63
[?] PE Ratio versus Sector 100% lower than other Unknown stocks
[?] PE Ratio versus Industry 100% lower than other Unknown stocks
[?] Cash Yield -7.63%
[?] Free Cash Flow Jitter 61%

Is Trius Therapeutics Stock on Sale?

Based on our analysis, we believe that you should not buy Trius Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy TSRX Stock?

Does Trius Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.